Valereum PLC (AQSE:VLRM, OTC:VBLXF) is to receive a £2 million injection to support its expansion and strategic growth plans.
Blue Sky Vision LLC has exercised an option to subscribe for 20 million shares in the company at 10p per share.
Completion of the share subscription is anticipated by the end of January 2025.
"This is a defining moment for Valereum, following a culmination of our efforts to source funding from strategic partners which bring synergistic benefits into Valereum,” chief executive Nick Cowan said in a statement.
“We are now focused on significantly accelerating the delivery of our vision.
“Together, we plan to scale the business to unprecedented heights and deliver significant value to our investors and stakeholders."